3-Bromo-8-chloro-1,7-naphthyridine

Catalog No.: 
ACMUJY817
CAS No.: 
1260670-05-0
Molecular Formula: 
C8H4BrClN2
Molecular Weight: 
243.49
3-Bromo-8-chloro-1,7-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$58.00In stockIn stock
5g98%$284.00In stockIn stock
25g98%$1377.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-8-chloro-1,7-naphthyridine
IUPAC Name3-bromo-8-chloro-1,7-naphthyridine
MDL No.MFCD18250850
Molecular FormulaC8H4BrClN2
Molecular Weight243.49
SMILESClC1=C2N=CC(Br)=CC2=CC=N1
InChI KeyDSPVDMUXVYEYPP-UHFFFAOYSA-N
Synonym1260670-05-0 | AB73781 | 3-BROMO-8-CHLORO-1,7-NAPHTHYRIDINE | AKOS027254418 | SY234076 | AMY26113 | AS-51261 | EN300-7421671 | P12248 | 3-bromo-8-chloro-[1,7]naphthyridine | MFCD18250850 | SB15505 | CS-0051445 | DSPVDMUXVYEYPP-UHFFFAOYSA-N | A857370 | SCH
CAS No.1260670-05-0
PubChem CID72213592

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMUJY817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKPOU270 route compound structure diagram
    ACKPOU2701375301-90-8In Stock
  4. Then
  5. ACMUJY817 route product structure diagram
    ACMUJY8171260670-05-0In Stock
Inquiry

2. ACMUJY817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMUJY817 route product structure diagram
    ACMUJY8171260670-05-0In Stock
Inquiry

3. ACMUJY817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMUJY817 route product structure diagram
    ACMUJY8171260670-05-0In Stock
Inquiry

Comments (0)